Liangxue Lai
lai_liangxue@gibh.ac.cn
English, Chinese
Guangdong
University of Chinese Academy of Sciences
Medical School
  • 1992-09--1995-07 PhD in Science: Northeast Agricultural University
  • 2007-12~Present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Researcher
  • 2006-07~2007-12 - Advanced Center for Reproductive Technology, USA - Senior Embryologist
  • 2004-07~2006-07 - National Swine Resource and Research Center, University of Missouri, USA - Research Assistant Professor
  • 2002-07~2004-07 - Animal Research Center, University of Missouri, USA - Research Assistant Professor
  • 1998-07~2002-07 - Animal Research Center, University of Missouri, USA - Postdoctoral Researcher
  • 1995-07~1997-07 - Transgenic Animal Laboratory, Military Veterinary Research Institute, PLA University of Agriculture and Animal Husbandry - Postdoctoral Researcher
  • 2016: First Prize for Innovation in Pig Gene Mutation Technology and Establishment of Gene-Modified Pig Models, Provincial Level
  • 2013: First Prize for Research on Large Animal Gene Modification Technology and Establishment of Gene-Modified Animal Models, Municipal Level
  • 2011: State Council Special Government Allowance, National Level
Animal Cloning and Embryonic Stem Cells
  • Generation of pigs with humanized type II collagen by precise human COL2A1 gene knock-in, Ting Lan, Yuling Zheng, Yangyang Suo, Yuhui Wei, Hui Shi, Quanmei Yan, Zhenpeng Zhuang, Huangyao Chen, Quanjun Zhang, Nana Fan, Yu Zhao, Zhen Ouyang, Chengdan Lai, Zhaoming Liu, Jizeng Zhou, Chengcheng Tang, NamHyung Kim, Qingjian Zou, Xiaomin Wang, 2023
  • Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington's disease, Yan, Sen, Zheng, Xiao, Lin, Yingqi, Li, Caijuan, Liu, Zhaoming, Li, Jiawei, Tu, Zhuchi, Zhao, Yu, Huang, Chunhui, Chen, Yizhi, Li, Jun, Song, Xichen, Han, Bofeng, Wang, Wei, Liang, Weien, Lai, Liangxue, Li, XiaoJiang, Li, Shihua, 2023
  • Doxycycline-dependent Cas9-expressing pig resources for conditional in vivo gene nullification and activation, Jin, Qin, Liu, Xiaoyi, Zhuang, Zhenpeng, Huang, Jiayuan, Gou, Shixue, Shi, Hui, Zhao, Yu, Ouyang, Zhen, Liu, Zhaoming, Li, Lei, Mao, Junjie, Ge, Weikai, Chen, Fangbing, Yu, Manya, Guan, Yezhi, Ye, Yinghua, Tang, Chengcheng, Huang, Ren, Wang, Kepin, Lai, Liangxue, 2023
  • Genome-Wide CRISPR/Cas9 Screen Reveals a Role for SLC35A1 in the Adsorption of Porcine Deltacoronavirus, Wang, Xunlei, Jin, Qin, Xiao, Wenwen, Fang, Puxian, Lai, Liangxue, Xiao, Shaobo, Wang, Kepin, Fang, Liurong, 2022
  • AGBE: a dual deaminase-mediated base editor by fusing CGBE with ABE for creating a saturated mutant population with multiple editing patterns, Liang, Yanhui, Xie, Jingke, Zhang, Quanjun, Wang, Xiaomin, Gou, Shixue, Lin, Lihui, Chen, Tao, Ge, Weikai, Zhuang, Zhenpeng, Lian, Meng, Chen, Fangbing, Li, Nan, Ouyang, Zhen, Lai, Chengdan, Liu, Xiaoyi, Li, Lei, Ye, Yinghua, Wu, Han, Wang, Kepin, Lai, Liangxue, 2022
  • Double knock-in pig models with elements of binary Tet-On and phiC31 integrase systems for controllable and switchable gene expression, Jin, Qin, Yang, Xiaoyu, Gou, Shixue, Liu, Xiaoyi, Zhuang, Zhenpeng, Liang, Yanhui, Shi, Hui, Huang, Jiayuan, Wu, Han, Zhao, Yu, Ouyang, Zhen, Zhang, Quanjun, Liu, Zhaoming, Chen, Fangbing, Ge, Weikai, Xie, Jingke, Li, Nan, Lai, Chengdan, Zhao, Xiaozhu, Wang, Jiawei, Lian, Meng, Li, Lei, Quan, Longquan, Ye, Yinghua, Lai, Liangxue, Wang, Kepin, 2022
  • Efficient multinucleotide deletions using deaminase-Cas9 fusions in human cells, Chen, Siyu, Liu, Zhiquan, Yu, Hao, Lai, Liangxue, Li, Zhanjun, 2022
  • 基因编辑猪中条件性基因修饰系统的研究进展, 刘晓艺, 金琴, 王可品, 赖良学, 2022
  • Efficient C-to-G Base Editing with Improved Target Compatibility Using Engineered Deaminase-nCas9 Fusions, Chen, Siyu, Liu, Zhiquan, Lai, Liangxue, Li, Zhanjun, 2022
  • Targeted mutagenesis in rabbit using an engineered BhCas12b variant, Yingqi Jia, Tian Wang, Ding Zhao, Zhiquan Liu, Tingting Sui, Siyu Chen, Jinze Li, Liangxue Lai, Zhanjun Li, Jinsong Li, 2022
  • Highly efficient A-to-G base editing by ABE8.17 in rabbits, Zhao, Ding, Qian, Yuqiang, Li, Jinze, Li, Zhanjun, Lai, Liangxue, 2022
  • Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9, Liu, Zhiquan, Chen, Siyu, Lai, Liangxue, Li, Zhanjun, 2022
  • Inhibition of base editors with anti-deaminases derived from viruses, Liu, Zhiquan, Chen, Siyu, Lai, Liangxue, Li, Zhanjun, 2022
  • PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition, Yating Sun, Dan Li, Hongmei Liu, Yongye Huang, Fanyu Meng, Jiahao Tang, Zhanjun Li, Wanhua Xie, 2022
  • Elimination of Cas9-dependent off-targeting of adenine base editor by using TALE to separately guide deaminase to target sites, Liu, Yang, Zhou, Jizeng, Lan, Ting, Zhou, Xiaoqing, Yang, Yang, Li, Chuan, Zhang, Quanjun, Chen, Min, Wei, Shu, Zheng, Shuwen, Cheng, Lingyin, Zheng, Yuling, Lai, Liangxue, Zou, Qingjian, 2022
  • Efficient and Safe Editing of Porcine Endogenous Retrovirus Genomes by Multiple-Site Base-Editing Editor, Zheng, Shuwen, Zhong, Haiwen, Zhou, Xiaoqing, Chen, Min, Li, Wansheng, Zi, Yin, Chi, Yue, Wang, Jinling, Zheng, Wei, Zou, Qingjian, Lai, Liangxue, Tang, Chengcheng, 2022
  • Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors, Chen, Fangbing, Lian, Meng, Ma, Bingxiu, Gou, Shixue, Luo, Xian, Yang, Kaiming, Shi, Hui, Xie, Jingke, Ge, Weika, Ouyang, Zhen, Lai, Chengdan, Li, Nan, Zhang, Quanjun, Jin, Qin, Liang, Yanhui, Chen, Tao, Wang, Jiaowei, Zhao, Xiaozhu, Li, Lei, Yu, Manya, Ye, Yinghua, Wang, Kepin, Wu, Han, Lai, Liangxue, 2022
  • Versatile and efficient genome editing with Neisseria cinerea Cas9, Liu, Zhiquan, Chen, Siyu, Xie, Wanhua, Yu, Hao, Lai, Liangxue, Li, Zhanjun, 2022
  • Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent stem cell therapy, Liu, Yang, Yang, Yang, Suo, Yangyang, Li, Chuan, Chen, Min, Zheng, Shuwen, Li, Hao, Tang, Chengcheng, Fan, Nana, Lan, Ting, Zhou, Jizeng, Li, Yingying, Wang, Jiaowei, Chen, Huangyao, Zou, Qingjian, Lai, Liangxue, 2022
  • Development of a rabbit model of Wiskott-Aldrich syndrome, Zhou, Juanjuan, Yan, Quanmei, Tang, Chengcheng, Liao, Yuan, Zhang, Quanjun, Wang, Xiaomin, Zhou, Xiaoqing, Lai, Liangxue, Zou, Qingjian, 2021
  • CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I, Li, Nan, Gou, Shixue, Wang, Jiaowei, Zhang, Quanjun, Huang, Xingyun, Xie, Jingke, Li, Li, Jin, Qin, Ouyang, Zhen, Chen, Fangbing, Ge, Weikai, Shi, Hui, Liang, Yanhui, Zhuang, Zhenpeng, Zhao, Xiaozhu, Lian, Meng, Ye, Yinghua, Quan, Longquan, Wu, Han, Lai, Liangxue, Wang, Kepin, 2021
  • Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide, Liu, Zhiquan, Chen, Siyu, Jia, Yingqi, Shan, Huanhuan, Chen, Mao, Song, Yuning, Lai, Liangxue, Li, Zhanjun, 2021
  • CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia, Yi Yang, Xiangjin Kang, Shiqi Hu, Bangzhu Chen, Yingjun Xie, Bing Song, Quanjun Zhang, Han Wu, Zhanhui Ou, Yexing Xian, Yong Fan, Xiaoping Li, Liangxue Lai, Xiaofang Sun, 2021
  • A tunable, rapid, and precise drug control of protein expression by combining transcriptional and post-translational regulation systems, Li, Li, Meng, Hongyi, Zhang, Jianmin, Liu, Yang, Zou, Qingjian, Gao, Yi, Yang, Huaqiang, Lai, Liangxue, 2021
  • Improving Cpf1
Animal Cloning Embryonic Stem Cells Gene Editing Transgenic Animals Crispr Gene Therapy Regenerative Medicine Biomedical Research Genetic Engineering Stem Cell Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.